Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Neurology(R) Neuroimmunology & Neuroinflammation|December 23, 2024
Long-Term Clinical and Biological Prognostic Factors of Anti-NMDA Receptor Encephalitis in ChildrenMaxime Mazowiecki, Lorraine Flet-Berliac, Julia Roux, et al.
Blood|February 11, 2020
Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programsEmmanuelle Six, Agathe Guilloux, Adeline Denis, et al.
Genome Medicine|September 29, 2018
T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiencyErik L Clarke, A Jesse Connell, Emmanuelle Six, et al.
Science (New York, N.Y.)|November 7, 2009
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophyNathalie Cartier, Salima Hacein-Bey-Abina, Cynthia C Bartholomae, et al.
The New England Journal of Medicine|March 2, 2017
Gene Therapy in a Patient with Sickle Cell DiseaseJean-Antoine Ribeil, Salima Hacein-Bey-Abina, Emmanuel Payen, et al.
Seminars in Arthritis and Rheumatism|November 14, 2018
Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysisJocelyn Quistrebert, Signe Hässler, Delphine Bachelet, et al.
The Journal of Clinical Investigation|August 9, 2008
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1Salima Hacein-Bey-Abina, Alexandrine Garrigue, Gary P Wang, et al.
Nature Communications|January 24, 2015
Site- and allele-specific polycomb dysregulation in T-cell leukaemiaJean-Marc Navarro, Aurore Touzart, Lydie C Pradel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapyAnnette Deichmann, Martijn H Brugman, Cynthia C Bartholomae, et al.
The Journal of Clinical Investigation|August 3, 2007
Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapyAnnette Deichmann, Salima Hacein-Bey-Abina, Manfred Schmidt, et al.
Pageof 10